21-44531087-G-A
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_144991.3(TSPEAR):c.589C>T(p.Arg197*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000565 in 1,613,608 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_144991.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.589C>T | p.Arg197* | stop_gained | 4/12 | ENST00000323084.9 | NP_659428.2 | |
TSPEAR | NM_001272037.2 | c.385C>T | p.Arg129* | stop_gained | 5/13 | NP_001258966.1 | ||
LOC124905038 | XR_007067905.1 | n.3579G>A | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.589C>T | p.Arg197* | stop_gained | 4/12 | 1 | NM_144991.3 | ENSP00000321987.4 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152134Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000319 AC: 80AN: 250544Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135702
GnomAD4 exome AF: 0.000597 AC: 873AN: 1461474Hom.: 1 Cov.: 31 AF XY: 0.000558 AC XY: 406AN XY: 727012
GnomAD4 genome AF: 0.000256 AC: 39AN: 152134Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74308
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 04, 2024 | Observed multiple times with another TSPEAR variant in unrelated patients in published literature with ectodermal dysplasia or oligodontia, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes in some cases (PMID: 34042254, 37009414); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27736875, 33144682, 37009414, 34042254) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change creates a premature translational stop signal (p.Arg197*) in the TSPEAR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSPEAR are known to be pathogenic (PMID: 34042254). This variant is present in population databases (rs139455627, gnomAD 0.06%). This premature translational stop signal has been observed in individuals with clinical features of ectodermal dysplasia (PMID: 34042254; Invitae). This variant is also known as c.385C>T, p.Arg129*. ClinVar contains an entry for this variant (Variation ID: 403572). For these reasons, this variant has been classified as Pathogenic. - |
Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Sep 21, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Aug 03, 2022 | This sequence variant is a single nucleotide substitution (C>T) at coding nucleotide 589 in the TSPEAR gene which changes the arginine 197 codon into an early termition sigl. As it occurs in exon 4 of 12, this variant is predicted to generate a non-functiol allele through the expression of a truncated protein or a loss of TSPEAR expression due to nonsense-mediated decay. This is a previously reported variant (ClinVar) which has been observed with a second variant in multiple individuals with ectodermal dysplasia with and without tooth agenesis (PMID: 34042254). This variant is present in 86 of 281928 alleles (0.03%) in the gnomAD control population dataset. Given the data, we consider this variant to be pathogenic. ACMG Criteria: PM3, PP4, PVS1 - |
TSPEAR-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 21, 2024 | The TSPEAR c.589C>T variant is predicted to result in premature protein termination (p.Arg197*). This variant, also reported as c.385C>T (p.Arg129*) using a different transcript (NM_001272037.1), has been reported in the homozygous and compound heterozygous states in individuals with TSPEAR-related disorders (Klee et al. 2021. PubMed ID: 33144682; Bowles et al. 2021. PubMed ID: 34042254; Jackson et al. 2023. PubMed ID: 37009414). This variant is reported in 0.059% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in TSPEAR are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2019 | - - |
TSPEAR-related disorder of tooth and hair follicle morphogenesis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Undiagnosed Diseases Network, NIH | Jun 25, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 25, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: One frameshift variant in the gene has been reported in a consanguineous family with AR deafness (Delmaghani 2012). Variant segregated in 2 affected siblings. Variant disrupts protein function when transfected into cells in vitro. Limited evidence for gene's association with disease. Does not meet criteria for reporting in BabySeq. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at